LATAM HealthTech CVC
Strategic roadmap to initiate & build out a LATAM HealthTech corporate venture
During Fall 2020, three students and I paired with a Peruvian healthcare corporation to develop a strategic framework for designing a corporate venture that’s especially suited to the partner company’s goals and current start-up landscape. Through the project, I gained experience and knowledge in:
Strategies for corporate investment
VC deal flow
Types of VC structures
LATAM entrepreneurial and VC landscape
Latest LATAM HealthTech trends
The Recommendation
When engaging with the partner corporation, it was apparent that they had little experience engaging with and investing in start-ups and other small companies within the region. Furthermore, the LATAM entrepreneurial landscape, especially in HeathTech, is young but fastly growing. There are few start-ups and those that exist are in the pre-seed and seed funding stages, both of which are less common to be supported by a VC.
Understanding this market, we proposed two main recommendations. In both, it requires the company to set aside a dedicated fund to satisfy short-term and long-term investments. A dedicated investment keeps incentives aligned with an investment thesis that has a return and exit. The recommendations are:
Initially invest indirectly through other VCs and/or angel investors to gain knowledge of the space, observe a broader deal flow set, and reduce risk. The corporation could even work with a particular VC to establish an industry vertical, such as healthcare. Then, once the start-ups grow, capitalize on successful ones by directly investing with a larger investment. Relationship terms with the VC or other investor must be negotiated.
Alternatively (or concurrently) strategically invest in R&D via collaborative venturing or sponsored acceleration. The company can focus innovation into workstreams by engaging with start-ups that are targeting a specific area of interest for the company. This approach is very hands-on- the company is a sponsor, mentor, and facilitator- but can lead to long-term gains that will benefit the corporation.